Drug Profile
AVE 0675
Alternative Names: AVE0675Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Coley Pharmaceutical Group
- Developer Coley Pharmaceutical GmbH; sanofi-aventis
- Class Antiasthmatics; Oligonucleotides
- Mechanism of Action Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 01 Jan 2008 Coley Pharmaceutical Group has been acquired by Pfizer